Sitagliptin/Ertugliflozin
N/A
Report date: 2022/03/09 20:00:20
Base Information
Drug NameSitagliptin/Ertugliflozin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2017/12/19
Country/Territory
CombinationsYes ErtugliflozinSitagliptin Phosphate Monohydrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesMerck Sharp & Dohme BvMerck & Co Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A